Cargando…

Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma

BACKGROUND: The key-stone-pathogen, Porphyromonas gingivalis associates not only with periodontal diseases but with a variety of other chronic diseases such as cancer. We previously reported an association between the presence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, She-Gan, Yang, Jun-Qiang, Ma, Zhi-Kun, Yuan, Xiang, Zhao, Chen, Wang, Guang-Chao, Wei, Hua, Feng, Xiao-Shan, Qi, Yi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753462/
https://www.ncbi.nlm.nih.gov/pubmed/29298684
http://dx.doi.org/10.1186/s12885-017-3905-1
_version_ 1783290274872557568
author Gao, She-Gan
Yang, Jun-Qiang
Ma, Zhi-Kun
Yuan, Xiang
Zhao, Chen
Wang, Guang-Chao
Wei, Hua
Feng, Xiao-Shan
Qi, Yi-Jun
author_facet Gao, She-Gan
Yang, Jun-Qiang
Ma, Zhi-Kun
Yuan, Xiang
Zhao, Chen
Wang, Guang-Chao
Wei, Hua
Feng, Xiao-Shan
Qi, Yi-Jun
author_sort Gao, She-Gan
collection PubMed
description BACKGROUND: The key-stone-pathogen, Porphyromonas gingivalis associates not only with periodontal diseases but with a variety of other chronic diseases such as cancer. We previously reported an association between the presence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC) and its progression. We now report the diagnostic and prognostic potential of serum immunoglobulin G and A antibodies (IgG/A) against Porphyromonas gingivalis for ESCC. METHODS: An enzyme-linked immunosorbent assay (ELISA) was used to determine the serum levels of Porphyromonas gingivalis IgG and IgA in 96 cases with ESCC, 50 cases with esophagitis and 80 healthy controls. RESULTS: The median serum levels of IgG and IgA for P. gingivalis were significantly higher in ESCC patients than non-ESCC controls. P. gingivalis IgG and IgA in serum demonstrated sensitivities/specificities of 29.17%/96.90% and 52.10%/70.81%, respectively, and combination of IgG and IgA produced a sensitivity/specificity of 68.75%/68.46%. The diagnostic performance of serum P. gingivalis IgA for early ESCC was superior to that of IgG (54.54% vs. 20.45%). Furthermore, high serum levels of P. gingivalis IgG or IgA were associated with worse prognosis of ESCC patients, in particular for patients with stage 0-IIor negative lymphnode metastasis, and ESCC patients with high levels of both IgG and IgA had the worst prognosis. Multivariate analysis revealed that lymph node status, IgG and IgA were independent prognostic factors. CONCLUSIONS: The IgG and IgA for P. gingivalis are potential serum biomarkers for ESCC and combination of IgG and IgA improves the diagnostic and prognostic performance. Furthermore, serum P. gingivalis IgG and IgA can detect early stage ESCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3905-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5753462
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57534622018-01-05 Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma Gao, She-Gan Yang, Jun-Qiang Ma, Zhi-Kun Yuan, Xiang Zhao, Chen Wang, Guang-Chao Wei, Hua Feng, Xiao-Shan Qi, Yi-Jun BMC Cancer Research Article BACKGROUND: The key-stone-pathogen, Porphyromonas gingivalis associates not only with periodontal diseases but with a variety of other chronic diseases such as cancer. We previously reported an association between the presence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC) and its progression. We now report the diagnostic and prognostic potential of serum immunoglobulin G and A antibodies (IgG/A) against Porphyromonas gingivalis for ESCC. METHODS: An enzyme-linked immunosorbent assay (ELISA) was used to determine the serum levels of Porphyromonas gingivalis IgG and IgA in 96 cases with ESCC, 50 cases with esophagitis and 80 healthy controls. RESULTS: The median serum levels of IgG and IgA for P. gingivalis were significantly higher in ESCC patients than non-ESCC controls. P. gingivalis IgG and IgA in serum demonstrated sensitivities/specificities of 29.17%/96.90% and 52.10%/70.81%, respectively, and combination of IgG and IgA produced a sensitivity/specificity of 68.75%/68.46%. The diagnostic performance of serum P. gingivalis IgA for early ESCC was superior to that of IgG (54.54% vs. 20.45%). Furthermore, high serum levels of P. gingivalis IgG or IgA were associated with worse prognosis of ESCC patients, in particular for patients with stage 0-IIor negative lymphnode metastasis, and ESCC patients with high levels of both IgG and IgA had the worst prognosis. Multivariate analysis revealed that lymph node status, IgG and IgA were independent prognostic factors. CONCLUSIONS: The IgG and IgA for P. gingivalis are potential serum biomarkers for ESCC and combination of IgG and IgA improves the diagnostic and prognostic performance. Furthermore, serum P. gingivalis IgG and IgA can detect early stage ESCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3905-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-03 /pmc/articles/PMC5753462/ /pubmed/29298684 http://dx.doi.org/10.1186/s12885-017-3905-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gao, She-Gan
Yang, Jun-Qiang
Ma, Zhi-Kun
Yuan, Xiang
Zhao, Chen
Wang, Guang-Chao
Wei, Hua
Feng, Xiao-Shan
Qi, Yi-Jun
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title_full Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title_fullStr Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title_full_unstemmed Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title_short Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
title_sort preoperative serum immunoglobulin g and a antibodies to porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753462/
https://www.ncbi.nlm.nih.gov/pubmed/29298684
http://dx.doi.org/10.1186/s12885-017-3905-1
work_keys_str_mv AT gaoshegan preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT yangjunqiang preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT mazhikun preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT yuanxiang preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT zhaochen preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT wangguangchao preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT weihua preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT fengxiaoshan preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma
AT qiyijun preoperativeserumimmunoglobulingandaantibodiestoporphyromonasgingivalisarepotentialserumbiomarkersforthediagnosisandprognosisofesophagealsquamouscellcarcinoma